Cargando…

Viral escape in the CNS with multidrug-resistant HIV-1

INTRODUCTION: HIV-1 viral escape in the cerebrospinal fluid (CSF) despite viral suppression in plasma is rare [1,2]. We describe the case of a 50-year-old HIV-1 infected patient who was diagnosed with HIV-1 in 1995. Antiretroviral therapy (ART) was started in 1998 with a CD4 T cell count of 71 cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Béguelin, Charles, Vázquez, Miriam, Bertschi, Manuel, Yerly, Sabine, de Jong, Denise, Rauch, Andri, Cusini, Alexia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P213
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225423/ https://www.ncbi.nlm.nih.gov/pubmed/25397490 http://dx.doi.org/10.7448/IAS.17.4.19745

Ejemplares similares

Viral Escape in the Central Nervous System with Multidrug-Resistant Human Immunodeficiency Virus-1
por: Béguelin, C., et al.
Publicado: (2015)

Taux de vaccination contre la COVID-19 chez le personnel de santé dans un Centre hospitalo-universitaire à Tunis (Tunisie)
por: Snène, H., et al.
Publicado: (2022)

Clinical-epidemiological features of HIV-infected patients diagnosed at age of 50 years or older
por: Patterson, P, et al.
Publicado: (2012)

Professional competences of the physiotherapists in the field of mental health in Portugal: a questionnaire based survey
por: Brito, Olena, et al.
Publicado: (2021)

CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-study
por: Pérez Valero, Ignacio, et al.
Publicado: (2014)

Use of maraviroc in patients with undetectable viral load: efficacy, tolerance and predictors of viral response in MARAVIROC-cohort study
por: Jesús Pérez Elías, María, et al.
Publicado: (2014)

CSF LPV concentrations and viral load in viral suppressed patients on LPV/r monotherapy given once daily
por: Tiraboschi, Juan, et al.
Publicado: (2014)

The importance of viral blips and duration of therapy initiated in primary infection in maintaining viral control after stopping cART
por: Fidler, Sarah, et al.
Publicado: (2014)

Longitudinal comparison of HIV-1 plasma viral load and cellular proviral load
por: Schweitzer, Finja, et al.
Publicado: (2014)

Service impact of a change in HIV-1 viral load quantification assay
por: Tipple, Craig, et al.
Publicado: (2014)

Early clinical response and presence of viral resistant minority variants: a proof of concept study
por: Callegaro, Annapaola, et al.
Publicado: (2014)

Long-term effect of a four-drugs induction regimen for patients with high baseline viral load
por: Maggiolo, Franco, et al.
Publicado: (2014)

Liver Fibrosis progression using Fibroscan in HIV/HCV coinfected patients with undetectable HIV viral load
por: Perez-Martinez, Laura, et al.
Publicado: (2014)

Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients
por: Mengoli, Carlo, et al.
Publicado: (2014)

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting
por: Gianotti, Nicola, et al.
Publicado: (2014)

Switching to nevirapine-based regimens after undetectable viral load is not associated with increased risk of discontinuation due to toxicity
por: Patterson, Patricia, et al.
Publicado: (2014)

Models of care and delivery
por: Lundgren, Jens
Publicado: (2014)

Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy
por: Davies, Olubanke, et al.
Publicado: (2014)

Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2014)

High rates of viral suppression in a cohort of HIV-positive adults receiving ART in Ethiopian health centers irrespective of concomitant tuberculosis
por: Reepalu, Anton, et al.
Publicado: (2014)

Four-drugs regimen containing raltegravir is highly effective in HIV patients starting therapy with >500,000 copies/mL viral load
por: Sterrantino, Gaetana, et al.
Publicado: (2014)

DRV concentrations and viral load in CSF in patients on DRV/r 600/100 or 800/100mg once daily plus two NRTI
por: Di Yacovo, Silvana, et al.
Publicado: (2014)

Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression
por: Carbone, Alessia, et al.
Publicado: (2014)

Lp-PLA2 levels in HIV-infected patients
por: Díaz-Pollán, Beatriz, et al.
Publicado: (2014)

Monotherapy with darunavir/ritonavir is effective and safe in clinical practice
por: Pasquau, Juan, et al.
Publicado: (2014)

Should screening for Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-men who have sex with men be recommended?
por: Pérez-Hernández, Isabel, et al.
Publicado: (2014)

Long-term fat redistribution in ARV-naïve HIV+ patients initiating a non-thymidine containing regimen in clinical practice
por: Ferrer, Elena, et al.
Publicado: (2014)

Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera(®)). Efficacy and safety analysis. GeSida Study 8114
por: Pérez-Hernández, Isabel A, et al.
Publicado: (2014)

Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naïve patients
por: Podzamczer, Daniel, et al.
Publicado: (2014)

ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study
por: Podzamczer, Daniel, et al.
Publicado: (2014)

Les éruptions virales aux urgences dermatologiques : étude comparative avant et après la pandémie COVID-19
por: Ben Kahla, Marouane, et al.
Publicado: (2021)

Comparison of HIV-1 drug resistance profiles generated from novel software applications for routine patient care
por: Gonzalez, Dimitri, et al.
Publicado: (2014)

Switching from an EFV-based STR to a RPV-based STR is effective, safe and improves HIV patients health status
por: Maggiolo, Franco, et al.
Publicado: (2014)

Pregnancy outcomes in women growing up with perinatally acquired HIV in the United Kingdom and Ireland
por: Byrne, Laura, et al.
Publicado: (2014)

Who gets single tablet regimens (STR), and why?
por: Tarrier, Laura, et al.
Publicado: (2014)

Lamivudine monotherapy as a safe option for HIV-infected paediatric clients with adherence challenges: new evidence from a large South African cohort
por: Linder, Verena, et al.
Publicado: (2014)

Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study
por: Fowler, Nikola, et al.
Publicado: (2014)

Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL
por: Dentone, Chiara, et al.
Publicado: (2014)

APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons
por: Libertone, Raffaella, et al.
Publicado: (2014)

Two years of Truvada for pre-exposure prophylaxis utilization in the US
por: Flash, Charlene, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_up81em70upaub4o3494e7gq11e